Modulating the activity of short arginine-tryptophan containing antibacterial peptides with N-terminal metallocenoyl groups

• H. Bauke Albada,
• Alina-Iulia Chiriac,
• Michaela Wenzel,
• Maya Penkova,
• Julia E. Bandow,
• Hans-Georg Sahl and
• Nils Metzler-Nolte

Beilstein J. Org. Chem. 2012, 8, 1753–1764, doi:10.3762/bjoc.8.200

• antibacterial and hemolysis studies. Discussion Ruthenium is one of the most promising metals in anticancer drug candidates [54][55][56][57], with two Ru-compounds even in clinical trials [58][59][60][61][62]. Surprisingly however, its potential in antibacterial research has not been explored so far. In this

Biosynthesis and function of secondary metabolites

• Jeroen S. Dickschat

Beilstein J. Org. Chem. 2011, 7, 1620–1621, doi:10.3762/bjoc.7.190

• awarded the Nobel Prize in 1945. The discovery of new bioactive natural products is still a fascinating field in organic chemistry as demonstrated by the recent paradigms of the anticancer drug epothilon, the immunosuppressant rapamycin, or the proteasome inhibitor salinosporamide, to name but a few of

Development of the titanium–TADDOLate-catalyzed asymmetric fluorination of β-ketoesters

• Lukas Hintermann,
• Mauro Perseghini and
• Antonio Togni

Beilstein J. Org. Chem. 2011, 7, 1421–1435, doi:10.3762/bjoc.7.166

• of a β-ketoester substructure (Figure 1c) [16]. Fluorinated agrochemicals and drugs are now produced industrially on a large scale by a range of methods, including reactions with notoriously reactive fluorine gas in the production of the anticancer drug fluorouracil (Figure 1d) [17]. However, many